{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:20:53Z","timestamp":1781133653861,"version":"3.54.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.7759\/cureus.25578","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T20:53:37Z","timestamp":1654116817000},"source":"Crossref","is-referenced-by-count":12,"title":["Epicardial Adipose Tissue as an Independent Cardiometabolic Risk Factor for Coronary Artery Disease"],"prefix":"10.7759","author":[{"given":"Nikoleta","family":"Karampetsou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Minia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaia","family":"Pliaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Tsolakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kontzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina N","family":"Perrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulos","family":"Patapis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.06.33","article-title":"Epidemiology of coronary heart disease and acute coronary syndrome","volume":"4","author":"Sanchis-Gomar F","year":"2016","unstructured":"Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016, 4:256. 10.21037\/atm.2016.06.33","journal-title":"Ann Transl Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000746","article-title":"Correction to: heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"141","year":"2020","unstructured":"Correction to. heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2020, 141:e33. 10.1161\/CIR.0000000000000746","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28350","article-title":"A review on coronary artery disease, its risk factors, and therapeutics","volume":"234","author":"Malakar AK","year":"2019","unstructured":"Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019, 234:16812-16823. 10.1002\/jcp.28350","journal-title":"J Cell Physiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.313608","article-title":"Coronary artery disease","volume":"40","author":"Agrawal H","year":"2020","unstructured":"Agrawal H, Choy HK, Liu J, Auyoung M, Albert MA. Coronary artery disease. Arterioscler Thromb Vasc Biol. 2020, 40:e185-e192. 10.1161\/ATVBAHA.120.313608","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1079","article-title":"Risk factors associated with major cardiovascular events 1 year after acute myocardial infarction","volume":"1","author":"Wang Y","year":"2018","unstructured":"Wang Y, Li J, Zheng X, et al.. Risk factors associated with major cardiovascular events 1 year after acute myocardial infarction. JAMA Netw Open. 2018, 1:e181079. 10.1001\/jamanetworkopen.2018.1079","journal-title":"JAMA Netw Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(21)00204-7","article-title":"Targeting visceral adiposity with pharmacotherapy","volume":"9","author":"Gadde KM","year":"2021","unstructured":"Gadde KM, Heymsfield SB. Targeting visceral adiposity with pharmacotherapy. Lancet Diabetes Endocrinol. 2021, 9:551-552. 10.1016\/s2213-8587(21)00204-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318093","article-title":"Obesity, adipose tissue and vascular dysfunction","volume":"128","author":"Koenen M","year":"2021","unstructured":"Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021, 128:951-968. 10.1161\/CIRCRESAHA.121.318093","journal-title":"Circ Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-017-9644-1","article-title":"Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease","volume":"22","author":"Patel VB","year":"2017","unstructured":"Patel VB, Shah S, Verma S, Oudit GY. Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease. Heart Fail Rev. 2017, 22:889-902. 10.1007\/s10741-017-9644-1","journal-title":"Heart Fail Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1113\/JP273049","article-title":"The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles","volume":"595","author":"Antonopoulos AS","year":"2017","unstructured":"Antonopoulos AS, Antoniades C. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol. 2017, 595:3907-3917. 10.1113\/JP273049","journal-title":"J Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20130138","article-title":"Epicardial fat: definition, measurements and systematic review of main outcomes","volume":"101","author":"Bertaso AG","year":"2013","unstructured":"Bertaso AG, Bertol D, Duncan BB, Foppa M. Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol. 2013, 101:e18-e28. 10.5935\/abc.20130138","journal-title":"Arq Bras Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2016.01.004","article-title":"Epicardial fat: a new cardiovascular therapeutic target","volume":"27","author":"Iacobellis G","year":"2016","unstructured":"Iacobellis G. Epicardial fat: a new cardiovascular therapeutic target. Curr Opin Pharmacol. 2016, 27:13-18. 10.1016\/j.coph.2016.01.004","journal-title":"Curr Opin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_194_19","article-title":"Relation of systolic and diastolic epicardial adipose tissue thickness with presence and severity of coronary artery disease (The EAT CAD study)","volume":"8","author":"Verma B","year":"2019","unstructured":"Verma B, Katyal D, Patel A, Singh VR, Kumar S. Relation of systolic and diastolic epicardial adipose tissue thickness with presence and severity of coronary artery disease (The EAT CAD study). J Family Med Prim Care. 2019, 8:1470-1475. 10.4103\/jfmpc.jfmpc_194_19","journal-title":"J Family Med Prim Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.09.089","article-title":"Epicardial adipose tissue and cardiovascular diseases","volume":"278","author":"Ansaldo AM","year":"2019","unstructured":"Ansaldo AM, Montecucco F, Sahebkar A, Dallegri F, Carbone F. Epicardial adipose tissue and cardiovascular diseases. Int J Cardiol. 2019, 278:254-260. 10.1016\/j.ijcard.2018.09.089","journal-title":"Int J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235989","article-title":"Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk","volume":"20","author":"Villasante Fricke AC","year":"2019","unstructured":"Villasante Fricke AC, Iacobellis G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int J Mol Sci. 2019, 20:5989. 10.3390\/ijms20235989","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000099542.57313.C5","article-title":"Human epicardial adipose tissue is a source of inflammatory mediators","volume":"108","author":"Mazurek T","year":"2003","unstructured":"Mazurek T, Zhang L, Zalewski A, et al.. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003, 108:2460-246. 10.1161\/01.CIR.0000099542.57313.C5","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v5.i6.868","article-title":"Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease","volume":"5","author":"Noyes AM","year":"2014","unstructured":"Noyes AM, Dua K, Devadoss R, Chhabra L. Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J Diabetes. 2014, 5:868-876. 10.4239\/wjd.v5.i6.868","journal-title":"World J Diabetes"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.58","article-title":"Local and systemic effects of the multifaceted epicardial adipose tissue depot","volume":"11","author":"Iacobellis G","year":"2015","unstructured":"Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015, 11:363-371. 10.1038\/nrendo.2015.58","journal-title":"Nat Rev Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20190770","article-title":"Novel imaging biomarkers: epicardial adipose tissue evaluation","volume":"93","author":"Monti CB","year":"2020","unstructured":"Monti CB, Codari M, De Cecco CN, Secchi F, Sardanelli F, Stillman AE. Novel imaging biomarkers: epicardial adipose tissue evaluation. Br J Radiol. 2020, 93:20190770. 10.1259\/bjr.20190770","journal-title":"Br J Radiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.844266","article-title":"Inflammation and cardiovascular diseases in the elderly: the role of epicardial adipose tissue","volume":"9","author":"Conte M","year":"2022","unstructured":"Conte M, Petraglia L, Poggio P, et al.. Inflammation and cardiovascular diseases in the elderly: the role of epicardial adipose tissue. Front Med (Lausanne). 2022, 9:844266. 10.3389\/fmed.2022.844266","journal-title":"Front Med (Lausanne)"},{"key":"ref20","article-title":"Comparison of epicardial and pericardial fat thickness assessed by echocardiography in African American and non-Hispanic White men: a pilot study","volume":"18","author":"Willens HJ","year":"2008","unstructured":"Willens HJ, G\u00f3mez-Mar\u00edn O, Chirinos JA, Goldberg R, Lowery MH, Iacobellis G. Comparison of epicardial and pericardial fat thickness assessed by echocardiography in African American and non-Hispanic White men: a pilot study. Ethn Dis. 2008, 18:311-316.","journal-title":"Ethn Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/0003319720984607","article-title":"Association of epicardial fat volume with the extent of coronary atherosclerosis and cardiovascular adverse events in asymptomatic patients with diabetes","volume":"72","author":"Venuraju SM","year":"2021","unstructured":"Venuraju SM, Lahiri A, Jeevarethinam A, Rakhit RD, Shah PK, Nilsson J. Association of epicardial fat volume with the extent of coronary atherosclerosis and cardiovascular adverse events in asymptomatic patients with diabetes. Angiology. 2021, 72:442-450. 10.1177\/0003319720984607","journal-title":"Angiology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/2042018820928824","article-title":"Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes?","volume":"11","author":"Christensen RH","year":"2020","unstructured":"Christensen RH, von Scholten BJ, Lehrskov LL, Rossing P, J\u00f8rgensen PG. Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes?. Ther Adv Endocrinol Metab. 2020, 11:10.1177\/2042018820928824","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2019.107192","article-title":"Relationships between visceral\/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome","volume":"46","author":"Gormez S","year":"2020","unstructured":"Gormez S, Erdim R, Akan G, et al.. Relationships between visceral\/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome. Cardiovasc Pathol. 2020, 46:107192. 10.1016\/j.carpath.2019.107192","journal-title":"Cardiovasc Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(02)00426-8","article-title":"Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesions","volume":"24","author":"Prati F","year":"2003","unstructured":"Prati F, Arbustini E, Labellarte A, et al.. Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesions. Eur Heart J. 2003, 24:329-336. 10.1016\/S0195-668X(02)00426-8","journal-title":"Eur Heart J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2021.666260","article-title":"Aging effects on epicardial adipose tissue","volume":"2","author":"Iacobellis G","year":"2021","unstructured":"Iacobellis G. Aging effects on epicardial adipose tissue. Frontiers. 2021, 2:10.3389\/fragi.2021.666260","journal-title":"Frontiers"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27376-3","article-title":"Transcriptional analysis of adipose tissue during development reveals depot-specific responsiveness to maternal dietary supplementation","volume":"8","author":"Fainberg HP","year":"2018","unstructured":"Fainberg HP, Birtwistle M, Alagal R, et al.. Transcriptional analysis of adipose tissue during development reveals depot-specific responsiveness to maternal dietary supplementation. Sci Rep. 2018, 8:9628. 10.1038\/s41598-018-27376-3","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0571","article-title":"Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat","volume":"94","author":"Sacks HS","year":"2009","unstructured":"Sacks HS, Fain JN, Holman B, et al.. Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab. 2009, 94:3611-3615. 10.1210\/jc.2009-0571","journal-title":"J Clin Endocrinol Metab"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-2083","article-title":"Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone","volume":"34","author":"Sacks HS","year":"2011","unstructured":"Sacks HS, Fain JN, Cheema P, et al.. Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone. Diabetes Care. 2011, 34:730-733. 10.2337\/dc10-2083","journal-title":"Diabetes Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer M","year":"2018","unstructured":"Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol. 2018, 71:2360-2372. 10.1016\/j.jacc.2018.03.509","journal-title":"J Am Coll Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-017-1020-z","article-title":"Epicardial adipose tissue: at the heart of the obesity complications","volume":"54","author":"Guglielmi V","year":"2017","unstructured":"Guglielmi V, Sbraccia P. Epicardial adipose tissue: at the heart of the obesity complications. Acta Diabetol. 2017, 54:805-812. 10.1007\/s00592-017-1020-z","journal-title":"Acta Diabetol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2021.02.008","article-title":"Epicardial fat and coronary artery disease: role of cardiac imaging","volume":"321","author":"Guglielmo M","year":"2021","unstructured":"Guglielmo M, Lin A, Dey D, Baggiano A, Fusini L, Muscogiuri G, Pontone G. Epicardial fat and coronary artery disease: role of cardiac imaging. Atherosclerosis. 2021, 321:30-38. 10.1016\/j.atherosclerosis.2021.02.008","journal-title":"Atherosclerosis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.03.025","article-title":"Proteostasis in epicardial versus subcutaneous adipose tissue in heart failure subjects with and without diabetes","volume":"1864","author":"Burgeiro A","year":"2018","unstructured":"Burgeiro A, Fonseca AC, Espinoza D, Carvalho L, Louren\u00e7o N, Antunes M, Carvalho E. Proteostasis in epicardial versus subcutaneous adipose tissue in heart failure subjects with and without diabetes. Biochim Biophys Acta Mol Basis Dis. 2018, 1864:2183-2198. 10.1016\/j.bbadis.2018.03.025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144987","article-title":"AMPK, mitochondrial function, and cardiovascular disease","volume":"21","author":"Wu S","year":"2020","unstructured":"Wu S, Zou MH. AMPK, mitochondrial function, and cardiovascular disease. Int J Mol Sci. 2020, 21:4987. 10.3390\/ijms21144987","journal-title":"Int J Mol Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2013.09.003","article-title":"Adiponectin receptors: a review of their structure, function and how they work","volume":"28","author":"Yamauchi T","year":"2014","unstructured":"Yamauchi T, Iwabu M, Okada-Iwabu M, Kadowaki T. Adiponectin receptors: a review of their structure, function and how they work. Best Pract Res Clin Endocrinol Metab. 2014, 28:15-23. 10.1016\/j.beem.2013.09.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c170046","article-title":"Adiponectin regulation and function","volume":"8","author":"Fang H","year":"2018","unstructured":"Fang H, Judd RL. Adiponectin regulation and function. Compr Physiol. 2018, 8:1031-1063. 10.1002\/cphy.c170046","journal-title":"Compr Physiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-016-0406-5","article-title":"Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis","volume":"15","author":"Du Y","year":"2016","unstructured":"Du Y, Ji Q, Cai L, et al.. Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis. Cardiovasc Diabetol. 2016, 15:90. 10.1186\/s12933-016-0406-5","journal-title":"Cardiovasc Diabetol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2007.03.005","article-title":"Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues","volume":"28","author":"Li Y","year":"2007","unstructured":"Li Y, Jiang C, Wang X, Zhang Y, Shibahara S, Takahashi K. Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues. Peptides. 2007, 28:1129-1143. 10.1016\/j.peptides.2007.03.005","journal-title":"Peptides"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1231081","article-title":"Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease","volume":"41","author":"Iacobellis G","year":"2009","unstructured":"Iacobellis G, di Gioia CR, Di Vito M, et al.. Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Horm Metab Res. 2009, 41:855-860. 10.1055\/s-0029-1231081","journal-title":"Horm Metab Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvw016","article-title":"Counteractive effects of omentin-1 against atherogenesis\u2020","volume":"110","author":"Watanabe K","year":"2016","unstructured":"Watanabe K, Watanabe R, Konii H, et al.. Counteractive effects of omentin-1 against atherogenesis\u2020. Cardiovasc Res. 2016, 110:118-128. 10.1093\/cvr\/cvw016","journal-title":"Cardiovasc Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21059","article-title":"Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease","volume":"23","author":"McAninch EA","year":"2015","unstructured":"McAninch EA, Fonseca TL, Poggioli R, et al.. Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. Obesity (Silver Spring). 2015, 23:1267-1278. 10.1002\/oby.21059","journal-title":"Obesity (Silver Spring)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-020-00478-z","article-title":"Quantification of epicardial fat using 3D cine Dixon MRI","volume":"20","author":"Henningsson M","year":"2020","unstructured":"Henningsson M, Brundin M, Scheffel T, Edin C, Viola F, Carlh\u00e4ll CJ. Quantification of epicardial fat using 3D cine Dixon MRI. BMC Med Imaging. 2020, 20:80. 10.1186\/s12880-020-00478-z","journal-title":"BMC Med Imaging"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2003.45","article-title":"Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction","volume":"11","author":"Iacobellis G","year":"2003","unstructured":"Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003, 11:304-310. 10.1038\/oby.2003.45","journal-title":"Obes Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20180562","article-title":"MRI-based assessment and characterization of epicardial and paracardial fat depots in the context of impaired glucose metabolism and subclinical left-ventricular alterations","volume":"92","author":"Rado SD","year":"2019","unstructured":"Rado SD, Lorbeer R, Gatidis S, et al.. MRI-based assessment and characterization of epicardial and paracardial fat depots in the context of impaired glucose metabolism and subclinical left-ventricular alterations. Br J Radiol. 2019, 92:20180562. 10.1259\/bjr.20180562","journal-title":"Br J Radiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-13-1-20","article-title":"Epicardial fat in the maintenance of cardiovascular health","volume":"13","author":"Wu Y","year":"2017","unstructured":"Wu Y, Zhang A, Hamilton DJ, Deng T. Epicardial fat in the maintenance of cardiovascular health. Methodist Debakey Cardiovasc J. 2017, 13:20-24. 10.14797\/mdcj-13-1-20","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.04.058","article-title":"Clinical significance of epicardial fat measured using cardiac multislice computed tomography","volume":"102","author":"Sarin S","year":"2008","unstructured":"Sarin S, Wenger C, Marwaha A, et al.. Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Am J Cardiol. 2008, 102:767-771. 10.1016\/j.amjcard.2008.04.058","journal-title":"Am J Cardiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-019-0817-3","article-title":"Perivascular adipose tissue and coronary atherosclerosis: from biology to imaging phenotyping","volume":"21","author":"Lin A","year":"2019","unstructured":"Lin A, Dey D, Wong DT, Nerlekar N. Perivascular adipose tissue and coronary atherosclerosis: from biology to imaging phenotyping. Curr Atheroscler Rep. 2019, 21:47. 10.1007\/s11883-019-0817-3","journal-title":"Curr Atheroscler Rep"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1118\/1.4817577","article-title":"Automatic quantification of epicardial fat volume on non-enhanced cardiac CT scans using a multi-atlas segmentation approach","volume":"40","author":"Shahzad R","year":"2013","unstructured":"Shahzad R, Bos D, Metz C, et al.. Automatic quantification of epicardial fat volume on non-enhanced cardiac CT scans using a multi-atlas segmentation approach. Med Phys. 2013, 40:091910. 10.1118\/1.4817577","journal-title":"Med Phys"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland IJ","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s JP, et al.. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019, 7:715-725. 10.1016\/S2213-8587(19)30084-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.52.139","article-title":"Enhanced inflammation in epicardial fat in patients with coronary artery disease","volume":"52","author":"Hirata Y","year":"2011","unstructured":"Hirata Y, Kurobe H, Akaike M, et al.. Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J. 2011, 52:139-142. 10.1536\/ihj.52.139","journal-title":"Int Heart J"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000251608.09329.9a","article-title":"Role of the Toll-like receptor 4\/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages","volume":"27","author":"Suganami T","year":"2007","unstructured":"Suganami T, Tanimoto-Koyama K, Nishida J, et al.. Role of the Toll-like receptor 4\/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol. 2007, 27:84-91. 10.1161\/01.ATV.0000251608.09329.9a","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2579","article-title":"Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease","volume":"94","author":"Baker AR","year":"2009","unstructured":"Baker AR, Harte AL, Howell N, et al.. Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab. 2009, 94:261-267. 10.1210\/jc.2007-2579","journal-title":"J Clin Endocrinol Metab"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-5-1","article-title":"Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease","volume":"5","author":"Baker AR","year":"2006","unstructured":"Baker AR, Silva NF, Quinn DW, et al.. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006, 5:1. 10.1186\/1475-2840-5-1","journal-title":"Cardiovasc Diabetol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021003","article-title":"Relationship between coronary atheroma, epicardial adipose tissue inflammation, and adipocyte differentiation across the human myocardial bridge","volume":"10","author":"McLaughlin T","year":"2021","unstructured":"McLaughlin T, Schnittger I, Nagy A, et al.. Relationship between coronary atheroma, epicardial adipose tissue inflammation, and adipocyte differentiation across the human myocardial bridge. J Am Heart Assoc. 2021, 10:e021003. 10.1161\/JAHA.121.021003","journal-title":"J Am Heart Assoc"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2468w","article-title":"Epicardial adipose tissue thickness and its association with the presence and severity of coronary artery disease in clinical setting: a cross-sectional observational study","volume":"8","author":"Sinha SK","year":"2016","unstructured":"Sinha SK, Thakur R, Jha MJ, et al.. Epicardial adipose tissue thickness and its association with the presence and severity of coronary artery disease in clinical setting: a cross-sectional observational study. J Clin Med Res. 2016, 8:410-419. 10.14740\/jocmr2468w","journal-title":"J Clin Med Res"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.918390","article-title":"Leptin expression in human epicardial adipose tissue is associated with local coronary atherosclerosis","volume":"25","author":"Zhang T","year":"2019","unstructured":"Zhang T, Yang P, Li T, Gao J, Zhang Y. Leptin expression in human epicardial adipose tissue is associated with local coronary atherosclerosis. Med Sci Monit. 2019, 25:9913-9922. 10.12659\/MSM.918390","journal-title":"Med Sci Monit"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20160134","article-title":"Obesity, serum resistin and leptin levels linked to coronary artery disease","volume":"107","author":"Montazerifar F","year":"2016","unstructured":"Montazerifar F, Bolouri A, Paghalea RS, Mahani MK, Karajibani M. Obesity, serum resistin and leptin levels linked to coronary artery disease. Arq Bras Cardiol. 2016, 107:348-353. 10.5935\/abc.20160134","journal-title":"Arq Bras Cardiol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0931-0","article-title":"Pericoronary fat inflammation and major adverse cardiac events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin","volume":"18","author":"Sardu C","year":"2019","unstructured":"Sardu C, D'Onofrio N, Torella M, et al.. Pericoronary fat inflammation and major adverse cardiac events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin. Cardiovasc Diabetol. 2019, 18:126. 10.1186\/s12933-019-0931-0","journal-title":"Cardiovasc Diabetol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.720690","article-title":"Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction-a specific HFpEF phenotype","volume":"8","author":"Elsanhoury A","year":"2021","unstructured":"Elsanhoury A, Nelki V, Kelle S, Van Linthout S, Tsch\u00f6pe C. Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction-a specific HFpEF phenotype. Front Cardiovasc Med. 2021, 8:720690. 10.3389\/fcvm.2021.720690","journal-title":"Front Cardiovasc Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/954045","article-title":"The association between the epicardial adipose tissue thickness and oxidative stress parameters in isolated metabolic syndrome patients: a multimarker approach","volume":"2014","author":"Demir B","year":"2014","unstructured":"Demir B, Demir E, Ac\u0131ksar\u0131 G, et al.. The association between the epicardial adipose tissue thickness and oxidative stress parameters in isolated metabolic syndrome patients: a multimarker approach. Int J Endocrinol. 2014, 2014:954045. 10.1155\/2014\/954045","journal-title":"Int J Endocrinol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2017.05.010","article-title":"Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue","volume":"27","author":"Camarena V","year":"2017","unstructured":"Camarena V, Sant D, Mohseni M, Salerno T, Zaleski ML, Wang G, Iacobellis G. Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue. Nutr Metab Cardiovasc Dis. 2017, 27:739-750. 10.1016\/j.numecd.2017.05.010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.145495","article-title":"Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation","volume":"6","author":"Vyas V","year":"2021","unstructured":"Vyas V, Blythe H, Wood EG, et al.. Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation. JCI Insight. 2021, 6:10.1172\/jci.insight.145495","journal-title":"JCI Insight"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04140.x","article-title":"Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue","volume":"76","author":"Salgado-Somoza A","year":"2012","unstructured":"Salgado-Somoza A, Teijeira-Fern\u00e1ndez E, Rubio J, Couso E, Gonz\u00e1lez-Juanatey JR, Eiras S. Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue. Clin Endocrinol (Oxf). 2012, 76:51-58. 10.1111\/j.1365-2265.2011.04140.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-14-4850","article-title":"Epicardial adipose tissue thickness is an independent predictor of critical and complex coronary artery disease by Gensini and syntax scores","volume":"43","author":"Erkan AF","year":"2016","unstructured":"Erkan AF, Tanindi A, Kocaman SA, Ugurlu M, Tore HF. Epicardial adipose tissue thickness is an independent predictor of critical and complex coronary artery disease by Gensini and syntax scores. Tex Heart Inst J. 2016, 43:29-37. 10.14503\/THIJ-14-4850","journal-title":"Tex Heart Inst J"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.04.002","article-title":"Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography","volume":"102","author":"Gorter PM","year":"2008","unstructured":"Gorter PM, de Vos AM, van der Graaf Y, et al.. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol. 2008, 102:380-385. 10.1016\/j.amjcard.2008.04.002","journal-title":"Am J Cardiol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01225-6","article-title":"Epicardial adipose tissue volume and coronary calcification among people living with diabetes: a cross-sectional study","volume":"20","author":"Cosson E","year":"2021","unstructured":"Cosson E, Nguyen MT, Rezgani I, et al.. Epicardial adipose tissue volume and coronary calcification among people living with diabetes: a cross-sectional study. Cardiovasc Diabetol. 2021, 20:35. 10.1186\/s12933-021-01225-6","journal-title":"Cardiovasc Diabetol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.07.026","article-title":"Impact of epicardial fat volume on coronary artery disease in symptomatic patients with a zero calcium score","volume":"167","author":"Ito T","year":"2013","unstructured":"Ito T, Suzuki Y, Ehara M, et al.. Impact of epicardial fat volume on coronary artery disease in symptomatic patients with a zero calcium score. Int J Cardiol. 2013, 167:2852-2858. 10.1016\/j.ijcard.2012.07.026","journal-title":"Int J Cardiol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm564","article-title":"Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women","volume":"29","author":"de Vos AM","year":"2008","unstructured":"de Vos AM, Prokop M, Roos CJ, et al.. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J. 2008, 29:777-783. 10.1093\/eurheartj\/ehm564","journal-title":"Eur Heart J"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.251","article-title":"Substantial changes in epicardial fat thickness after weight loss in severely obese subjects","volume":"16","author":"Iacobellis G","year":"2008","unstructured":"Iacobellis G, Singh N, Wharton S, Sharma AM. Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring). 2008, 16:1693-1697. 10.1038\/oby.2008.251","journal-title":"Obesity (Silver Spring)"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18063136","article-title":"Epicardial adipose tissue and cardiovascular risk assessment in ultra-marathon runners: a pilot study","volume":"18","author":"Konwerski M","year":"2021","unstructured":"Konwerski M, Postu\u0142a M, Barczuk-Fal\u0119cka M, et al.. Epicardial adipose tissue and cardiovascular risk assessment in ultra-marathon runners: a pilot study. Int J Environ Res Public Health. 2021, 18:3136. 10.3390\/ijerph18063136","journal-title":"Int J Environ Res Public Health"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13103","article-title":"Physical exercise and epicardial adipose tissue: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Saco-Ledo G","year":"2021","unstructured":"Saco-Ledo G, Valenzuela PL, Castillo-Garc\u00eda A, Arenas J, Le\u00f3n-Sanz M, Ruilope LM, Lucia A. Physical exercise and epicardial adipose tissue: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2021, 22:e13103. 10.1111\/obr.13103","journal-title":"Obes Rev"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2018.02.001","article-title":"Impact of weight loss on epicardial fat and carotid intima-media thickness after laparoscopic sleeve gastrectomy: a prospective study","volume":"28","author":"Altin C","year":"2018","unstructured":"Altin C, Erol V, Aydin E, et al.. Impact of weight loss on epicardial fat and carotid intima-media thickness after laparoscopic sleeve gastrectomy: a prospective study. Nutr Metab Cardiovasc Dis. 2018, 28:501-509. 10.1016\/j.numecd.2018.02.001","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-017-0650-3","article-title":"Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins","volume":"17","author":"Kang J","year":"2018","unstructured":"Kang J, Kim YC, Park JJ, et al.. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins. Cardiovasc Diabetol. 2018, 17:10. 10.1186\/s12933-017-0650-3","journal-title":"Cardiovasc Diabetol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle A","year":"2017","unstructured":"Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017, 120:229-243. 10.1161\/CIRCRESAHA.116.308537","journal-title":"Circ Res"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013104","article-title":"Statins reduce epicardial adipose tissue attenuation independent of lipid lowering: a potential pleiotropic effect","volume":"8","author":"Raggi P","year":"2019","unstructured":"Raggi P, Gadiyaram V, Zhang C, Chen Z, Lopaschuk G, Stillman AE. Statins reduce epicardial adipose tissue attenuation independent of lipid lowering: a potential pleiotropic effect. J Am Heart Assoc. 2019, 8:e013104. 10.1161\/JAHA.119.013104","journal-title":"J Am Heart Assoc"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1348913","article-title":"PCSK9 expression in epicardial adipose tissue: molecular association with local tissue inflammation","volume":"2020","author":"Dozio E","year":"2020","unstructured":"Dozio E, Ruscica M, Vianello E, et al.. PCSK9 expression in epicardial adipose tissue: molecular association with local tissue inflammation. Mediators Inflamm. 2020, 2020:1348913. 10.1155\/2020\/1348913","journal-title":"Mediators Inflamm"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/ehaa946.3008","article-title":"Reduction of epicardial adipose tissue thickness with PCSK9inhibitors","volume":"41","author":"Rivas Galvez RE","year":"2020","unstructured":"Rivas Galvez RE, Morales Portano JD, Trujillo Cortes R, Gomez Alvarez EB, Sanchez Cubias SM, Zelaya SM. Reduction of epicardial adipose tissue thickness with PCSK9inhibitors. European Heart Journal. 2020, 41:ehaa946.3008. 10.1093\/ehjci\/ehaa946.3008","journal-title":"European Heart Journal"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.039586","article-title":"Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction","volume":"126","author":"Greulich S","year":"2012","unstructured":"Greulich S, Maxhera B, Vandenplas G, et al.. Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction. Circulation. 2012, 126:2324-2334. 10.1161\/CIRCULATIONAHA.111.039586","journal-title":"Circulation"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2018.08.010","article-title":"Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients","volume":"38","author":"Ziyrek M","year":"2019","unstructured":"Ziyrek M, Kahraman S, Ozdemir E, Dogan A. Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients. Rev Port Cardiol (Engl Ed). 2019, 38:419-423. 10.1016\/j.repc.2018.08.010","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-6-47","article-title":"Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome","volume":"6","author":"Grosso AF","year":"2014","unstructured":"Grosso AF, de Oliveira SF, Higuchi Mde L, Favarato D, Dallan LA, da Luz PL. Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome. Diabetol Metab Syndr. 2014, 6:47. 10.1186\/1758-5996-6-47","journal-title":"Diabetol Metab Syndr"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0710-y","article-title":"Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: a pilot study","volume":"51","author":"Lima-Mart\u00ednez MM","year":"2016","unstructured":"Lima-Mart\u00ednez MM, Paoli M, Rodney M, Balladares N, Contreras M, D'Marco L, Iacobellis G. Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: a pilot study. Endocrine. 2016, 51:448-455. 10.1007\/s12020-015-0710-y","journal-title":"Endocrine"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.04.039","article-title":"Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: a target to modulate cardiovascular risk?","volume":"292","author":"Dozio E","year":"2019","unstructured":"Dozio E, Vianello E, Malavazos AE, Tacchini L, Schmitz G, Iacobellis G, Corsi Romanelli MM. Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: a target to modulate cardiovascular risk?. Int J Cardiol. 2019, 292:218-224. 10.1016\/j.ijcard.2019.04.039","journal-title":"Int J Cardiol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-014-0710-z","article-title":"Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study","volume":"52","author":"Morano S","year":"2015","unstructured":"Morano S, Romagnoli E, Filardi T, et al.. Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study. Acta Diabetol. 2015, 52:727-732. 10.1007\/s00592-014-0710-z","journal-title":"Acta Diabetol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvz042","article-title":"Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity","volume":"4","author":"Iacobellis G","year":"2020","unstructured":"Iacobellis G, Villasante Fricke AC. Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity. J Endocr Soc. 2020, 4:bvz042. 10.1210\/jendso\/bvz042","journal-title":"J Endocr Soc"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21718","article-title":"Liraglutide causes large and rapid epicardial fat reduction","volume":"25","author":"Iacobellis G","year":"2017","unstructured":"Iacobellis G, Mohseni M, Bianco SD, Banga PK. Liraglutide causes large and rapid epicardial fat reduction. Obesity (Silver Spring). 2017, 25:311-316. 10.1002\/oby.21718","journal-title":"Obesity (Silver Spring)"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 inhibitors on kidney and cardiovascular function","volume":"83","author":"Vallon V","year":"2021","unstructured":"Vallon V, Verma S. Effects of SGLT2 inhibitors on kidney and cardiovascular function. Annu Rev Physiol. 2021, 83:503-528. 10.1146\/annurev-physiol-031620-095920","journal-title":"Annu Rev Physiol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22864","article-title":"SGLT2 inhibition, visceral adiposity, weight, and type 2 diabetes mellitus","volume":"28","author":"Carbone S","year":"2020","unstructured":"Carbone S, O'Keefe JH, Lavie CJ. SGLT2 inhibition, visceral adiposity, weight, and type 2 diabetes mellitus. Obesity (Silver Spring). 2020, 28:1173. 10.1002\/oby.22864","journal-title":"Obesity (Silver Spring)"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-017-0658-8","article-title":"The effect of dapagliflozin treatment on epicardial adipose tissue volume","volume":"17","author":"Sato T","year":"2018","unstructured":"Sato T, Aizawa Y, Yuasa S, et al.. The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc Diabetol. 2018, 17:6. 10.1186\/s12933-017-0658-8","journal-title":"Cardiovasc Diabetol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1596","article-title":"Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial","volume":"21","author":"Anker SD","year":"2019","unstructured":"Anker SD, Butler J, Filippatos GS, et al.. Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial. Eur J Heart Fail. 2019, 21:1279-1287. 10.1002\/ejhf.1596","journal-title":"Eur J Heart Fail"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1554688","article-title":"Body composition and epicardial fat in type 2 diabetes patients following insulin detemir versus insulin glargine initiation","volume":"48","author":"Elisha B","year":"2016","unstructured":"Elisha B, Azar M, Taleb N, Bernard S, Iacobellis G, Rabasa-Lhoret R. Body composition and epicardial fat in type 2 diabetes patients following insulin detemir versus insulin glargine initiation. Horm Metab Res. 2016, 48:42-47. 10.1055\/s-0035-1554688","journal-title":"Horm Metab Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/98643-epicardial-adipose-tissue-as-an-independent-cardiometabolic-risk-factor-for-coronary-artery-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:46Z","timestamp":1707507406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/98643-epicardial-adipose-tissue-as-an-independent-cardiometabolic-risk-factor-for-coronary-artery-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":89,"URL":"https:\/\/doi.org\/10.7759\/cureus.25578","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}